Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study. // Clinical Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1525730426001464?dgcid=rss_sd_all
Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study. Clinical Lung Cancer. https://www.sciencedirect.com/science/article/pii/S1525730426001464?dgcid=rss_sd_all
“Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study.” Clinical Lung Cancer.
@article{article40881,
title = {Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study},
journal = {Clinical Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1525730426001464?dgcid=rss_sd_all}
}